Africa’s most developed pharmaceutical market reviews 12 Ozempic generics as drugmakers target Novo Nordisk’s dominance

A major battle over the cost of blockbuster diabetes and weight-loss drugs is unfolding in Africa as South Africa reviews 12 applications for generic versions of semaglutide, the active ingredient in Novo Nordisk’s Ozempic and Wegovy.